
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients* Real-World Effectiveness of Nirmatrelvir–Ritonavir Against Severe Outcomes of COVID-19 in Taiwan: A Nationwide Population-Based Cohort StudyThree Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage* Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Free AI-powered recaps of Sensible Medicine and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.